Navigation Links
St. Joseph's scientist receives grant for post-partum research
Date:7/26/2011

(Phoenix Arizona, July 25, 2011) -- The Bill and Melinda Gates Foundation has awarded Robert Garfield, PhD, a researcher at St. Joseph's Hospital and Medical Center in Phoenix, a $100,000 phase 1 grant to develop a device to prevent post-partum hemorrhage.

The grant was one of 88 awarded in round six of Grand Challenges Explorations, a Gates Foundation initiative to help lower the barriers for testing innovative ideas in global health. Phase II of the grant will amount to $1 million.

Dr. Garfield is the director of research in the Department of Obstetrics and Gynecology at St. Joseph's. His research includes postpartum hemorrhage and preterm labor, two of the biggest problems facing pregnant women. The studies are also receiving additional funding from St. Joseph's Research Foundation and the National Institute of Health.

"Post-partum hemorrhage is the major cause of mortality in pregnant women. Worldwide, every minute one woman dies from complications of pregnancy with post-partum hemorrhage contributing more than 30 percent to this high mortality," says Dr. Garfield. "These studies, which are supported by the grant, can lead to important new ways to control bleeding in women following deliver of their babies."

The Gates Foundation grant will specifically assist Dr. Garfield in developing a compact, battery-powered device to electrically stimulate uterine contraction and prevent profuse bleeding following childbirth. The instrument could be used by any individual to reduce life-threatening postpartum hemorrhage in hospitals and in remote areas where prompt action is necessary.

"Minor post-partum hemorrhage is usually well controlled in developed countries like the United States with excellent medical facilities, doctors and medications," says Dr. Garfield. "However, major post-partum hemorrhage is a huge problem in underdeveloped countries."


'/>"/>

Contact: Lynne Reaves
602-406-4734
St. Joseph's Hospital and Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. Scientist plans to test for blood pressure genes affected by age
3. Scientists identify novel inhibitor of human microRNA
4. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
5. MU scientists go green with gold, distribute environmentally friendly nanoparticles
6. Scientists identify gene that may contribute to improved rice yield
7. Scientists discover why a mothers high-fat diet contributes to obesity in her children
8. MU scientists see how HIV matures into an infection
9. Earth scientists keep an eye on Texas
10. Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability
11. Scientists identify a molecule that coordinates the movement of cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology: